Key Insights

Highlights

Success Rate

100% trial completion (above average)

Treatment Research

2 treatments under study, led by Targeting Spo2 At 9092

Related Conditions

Often studied with 4 related conditions

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 1 trials

Success Rate

100.0%

+13.4% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed with results

Key Signals

100% success

Data Visualizations

Phase Distribution

1Total
Not Applicable (1)

Trial Status

Completed1

Trial Success Rate

100.0%

Benchmark: 86.6%

Based on 1 completed trials

Clinical Trials (1)

Showing 1 of 1 trials
NCT03695900Not ApplicableCompleted

Arterial Oxygen Saturation on Ventilatory Stability in Extremely Premature Infants

Showing all 1 trials

Research Network

Common Treatments

  • Targeting Spo2 At 90921
  • Targeting Spo2 At 93951

Active Sponsors

  • University of Miami1
  • The Gerber Foundation1

Top Investigators

Related Conditions

  • Apnea Of Prematurity1
  • Desaturation Of Blood1
  • Periodic Breathing1
  • Central Apnea1

Activity Timeline